BB1 ASX · Health Care

Blinklab Ltd

Announcements, last 12 months: 75
Price sensitive, last 12 months: 16
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
22 Oct 2026, 9:39 AM	Commencement of Nationwide Autism Screening in Morocco
13 Oct 2026, 9:13 AM	BB1 to Present at Simons Foundation and ThinkEquity in NYC
9 Oct 2026, 9:38 AM	BB1 to Present at Spark Plus Aussie Equities Day Singapore
17 Sep 2026, 8:51 AM	BB1 to Present at NSSpain - Apple Developer Conference
11 Sep 2026, 2:57 PM	Change of Director's Interest Notice x3
10 Sep 2026, 7:10 PM	Section 708A Notice
10 Sep 2026, 7:07 PM	Application for quotation of securities - BB1
10 Sep 2026, 8:30 AM	Initial Director's Interest Notice
10 Sep 2026, 8:29 AM	Final Director's Interest Notice
10 Sep 2026, 8:29 AM	Notification regarding unquoted securities - BB1

Sign in to see all BB1 announcements.

Guidance history

5 Aug 2026	Blinklab Ltd achieved 82% sensitivity and 83% specificity in the European ADHD study.
24 Mar 2026	No high-importance, price-sensitive forward-looking financial metrics provided.
23 Mar 2026	The Moroccan government-funded autism screening program is not intended to generate immediate revenue for BlinkLab. All program-related costs, including infrastructure, hardware, data storage, and implementation expenses, will be funded by the Moroccan government and associated Foundation partners. No material capital expenditure is expected to be borne by BlinkLab as part of this initiative.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow BB1 to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.